Federated Hermes’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.1K | Buy |
85,421
+26,212
| +44% | +$30.4K | ﹤0.01% | 1586 |
|
|
2025
Q1 | $79.9K | Buy |
59,209
+55,637
| +1,558% | +$75.1K | ﹤0.01% | 1597 |
|
|
2024
Q4 | $47K | Buy |
3,572
+1,363
| +62% | +$18K | ﹤0.01% | 1683 |
|
|
2024
Q3 | $24.8K | Buy |
+2,209
| New | +$24.8K | ﹤0.01% | 1736 |
|
|
2023
Q2 | – | Sell |
-79,732
| Closed | -$2.12M | – | 2197 |
|
|
2023
Q1 | $2.12M | Hold |
79,732
| – | – | 0.01% | 939 |
|
|
2022
Q4 | $1.54M | Hold |
79,732
| – | – | ﹤0.01% | 998 |
|
|
2022
Q3 | $1.67M | Sell |
79,732
-251,763
| -76% | -$5.26M | ﹤0.01% | 966 |
|
|
2022
Q2 | $2.66M | Buy |
331,495
+66,323
| +25% | +$531K | 0.01% | 853 |
|
|
2022
Q1 | $1.86M | Buy |
265,172
+228,554
| +624% | +$1.6M | ﹤0.01% | 1059 |
|
|
2021
Q4 | $494K | Buy |
+36,618
| New | +$494K | ﹤0.01% | 1485 |
|